You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 9,546,372


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,546,372
Title:Regulatory elements and uses thereof
Abstract: The present application provides novel regulatory elements including promoter sequences from marine microorganisms. The application further discloses DNA constructs containing these novel regulatory elements; transgenic cells, transgenic non-human organisms, and progeny containing these novel regulatory elements. Methods of modifying, producing, and using the regulatory elements are also disclosed. The regulatory elements disclosed herein are particularly suited for use in Nannochloropsis and other microalgae.
Inventor(s): Champagne; Michele M. (San Diego, CA), Richardson; Toby H. (San Diego, CA), Urano; Jun (Irvine, CA)
Assignee: Synthetic Genomics, Inc. (La Jolla, CA)
Application Number:13/915,522
Patent Claims:1. An isolated nucleic acid molecule, comprising a nucleic acid sequence exhibiting 90% or greater sequence identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 16, operably linked a heterologous polynucleotide sequence encoding a protein of interest.

2. The nucleic acid molecule according to claim 1, wherein said nucleic acid sequence comprises a promoter.

3. The nucleic acid molecule according to claim 2, wherein said promoter comprises one or more cis-acting elements.

4. The nucleic acid molecule according to claim 1, wherein said nucleic acid molecule comprises a 5' untranslated sequence.

5. The nucleic acid molecule according to claim 1, wherein said heterologous polynucleotide is operably linked to a 3' untranslated region.

6. The nucleic acid molecule according to claim 1, wherein said nucleic acid molecule comprises an intron.

7. A nucleic acid construct comprising a nucleic acid molecule according to claim 1, wherein said nucleic acid sequence comprises a promoter.

8. The nucleic acid construct according to claim 7, wherein said heterologous polynucleotide sequence is operably linked to a 3' transcription termination polynucleotide sequence.

9. The nucleic acid construct according to claim 7, wherein said heterologous polynucleotide molecule encodes a gene involved in modulating the phenotype of a trait selected from the group consisting of carbohydrate content, cell wall components, enzyme production, growth and development, herbicide tolerance, isoprenoid content, modified amino acid content, modified biomass yield, modified fatty acid/oil content, modified oil production, nitrogen utilization, photosynthesis capacity, and production of pigments.

10. The nucleic acid construct according to claim 7, wherein said heterologous polynucleotide molecule encodes a gene involved in modulating herbicide tolerance.

11. The nucleic construct of claim 10, wherein said nucleic acid sequence encodes an enzymatic activity selected from the group consisting of acetyl coenzyme-A carboxylase (ACCase), aminoglycoside phosphotransferase, anthranilate synthase, bromoxynil resistant nitrilase, cytochrome P450-NADH-cytochrome P450 oxidoreductase, dalapon dehalogenase, glutathione reductase, glyphosate acetyl transferase, glyphosate oxidoreductase, glyphosate resistant EPSPS, hydroxyacetoacid synthase (AHAS), hydroxyphenyl pyruvate dehydrogenase (HPPD), isoprenyl pyrophosphate isomerase, lycopene cyclase, phosphinothricin acetyl transferase (PAT), phytoene desaturase, prenyl transferase, protoporphyrinogen oxidase, and superoxide dismutase (SOD).

12. An isolated transformed microbial or plant cell comprising a nucleic acid construct according to claim 1.

13. The isolated cell according to claim 12, wherein said cell is a microbial cell.

14. The isolated cell according to claim 13, wherein said microbial cell is a microalgal cell.

15. The isolated cell according to claim 12, wherein said cell is stably transformed with said nucleic acid construct.

16. A method of making a transformed cell, wherein said method comprises introducing into an isolated plant or microbial cell a nucleic acid molecule according to claim 1.

17. The method according to claim 16, wherein the transformed cell is a microalgal cell.

18. An isolated nucleic acid molecule, comprising a nucleic acid sequence that comprises at least 300 contiguous nucleotides consisting of any of SEQ ID NO: 1-16, operably linked to a heterologous polynucleotide sequence encoding a protein of interest.

19. The nucleic acid construct comprising a nucleic acid molecule according to claim 18, wherein said nucleic acid sequence comprises a promoter.

20. The nucleic acid construct according to claim 19 wherein said heterologous polynucleotide encodes a gene involved in modulating the phenotype of a trait selected from the group consisting of carbohydrate content, cell wall components, enzyme production, growth and development, herbicide tolerance, isoprenoid content, modified amino acid content, modified biomass yield, modified fatty acid/oil content, modified oil production, nitrogen utilization, photosynthesis capacity, and production of pigments.

21. An isolated transformed plant or microbial cell comprising a nucleic acid construct according to claim 19.

22. The isolated transformed cell according to claim 21, wherein said transgenic cell is a microbial cell.

23. The isolated transformed cell according to claim 22, wherein said microbial cell is a microalgal cell.

Details for Patent 9,546,372

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.